Different approaches in the management of macular hemorrhage: Case reports and a literature review

• Main Authors: Jaime Leonel Quiroz-Mendoza, Diego Alejandro Valera-Cornejo, Marlon García-Roa, Paulina Ramírez-Neria, Yolanda Villalpando-Gómez, Verónica Romero-Morales, Renata García-Franco
• Format: Article
• Language: English
• Published: Medwave Estudios Limitada 2020-03-01
• Series: Medwave
• Subjects: retinal hemorrhage; eye hemorrhage; ranibizumab; lasers; solid-state; vitrectomy
• Online Access: https://www.medwave.cl/link.cgi/Medwave/Estudios/Casos/7831

Introduction Macular hemorrhages result in a sudden and profound loss of vision. The primary treatment modalities include observation, intravitreal injection of antiangiogenic drugs, neodymium-doped yttrium aluminum garnet hialoidotomy, intravitreal injection of gas with or without tissue plasminogen activator, as monotherapy or combined with surgery. In this paper, we report four cases of macular hemorrhages of different causes treated with different approaches, and we review the literature in this regard. Case presentation All four patients presented different causes of macular hemorrhage. The first case had a preretinal hemorrhage due to a Valsalva retinopathy and was treated with surgery. Case 2 had a multilevel macular hemorrhage due to a rupture of a retinal arteriolar macroaneurysm and was treated with pneumatic displacement, laser, and intravitreal ranibizumab. Case 3 presented an extensive subretinal hemorrhage due to a choroidal rupture after high-energy ocular trauma that was also successfully treated with surgery. The last case was a preretinal hemorrhage due to diabetic retinopathy managed with neodymium-doped yttrium aluminum garnet laser. Different treatment approaches were successfully performed in all cases with good outcomes. Conclusion There is an extensive range of options available for the management of macular hemorrhages, and the best option depends on the characteristics of each particular case. Proper and timely management of these diseases can achieve an excellent visual outcome, especially if the location of the hemorrhage is preretinal.